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Abstract
X-ray studies show that influenza hemagglutinin (HA) forms an elongated structure connecting the influenza virus at one end to cell-
surface receptors at the other. At neutral pH, the 20 N-terminal residues of HA2—referred to as the fusion peptide—are buried in a
hydrophobic pocket, about 100 A˚ away from the receptor-binding site, and thus seem unlikely to affect HA binding to the receptor. To test
this assumption, we mutated residues in the fusion peptide, heterologically expressed the mutated proteins in COS7 cells, and examined their
ability to bind fluorescently labeled red blood cells (RBCs). Surprisingly, a significantly reduced binding was recorded for some of the
mutants. Ample experimental data indicate that HA has at least two forms: the native structure at neutral pH (N) that is metastable and the
fusogenic form (F), observed at low pH, which is stable. Thus, a simple interpretation of our data is that HA can bind to its receptors at the
RBC surface in the N form much more effectively than in the F (or in any other stable) form and that the altered binding properties are due to
destabilizing effects of the mutations on the N form. That is, some of the mutations involve reduction in the free energy barrier between the N
and F forms. This, in turn, leads to reduction in the population of the N form, which is the only form capable of binding to the cell-surface
receptors. To explore this possibility, we estimated the stability free energy difference between HAwild-type (wt) and mutants in the N form
using an empirical surface tension coefficient. The calculated stability differences correlated well with the measured binding, supporting the
above interpretation. Our results are examined taking into account the available experimental data on the affinity of different soluble and
membrane-attached forms of HA to its receptors.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Infection of animal cells by the influenza virus begins
with binding of the virus via its hemagglutinin (HA) protein
to sialic acid residues, present in membrane proteins and
lipids. The bound virion is then internalized into endosomes
by receptor-mediated endocytosis. Ultimately, the viral
envelope fuses with the mature endosomal membrane after
the HA protein becomes fusogenic in response to a drop in
pH [1–6]. The HA from the X:31 strain is produced as a
550-residue-long precursor, called HA0, which is proteolyti-
cally cleaved into two subunits: HA1 (residues 1–328 of
HA0) and HA2 (residues 330–550). HA1 and HA2 are
covalently bonded by a disulfide bond.
HA has been studied intensively using molecular biol-
ogy, biochemical and biophysical methods. The site that
binds to the sialic acid-containing receptors was identified
on the HA1 subunit, and a hydrophobic segment containing
the first 20 residues of HA2 was shown to be involved in
membrane fusion and was termed ‘‘the fusion peptide.’’ The
X-ray crystal structure of HA has been determined in three
different forms: (a) the HA0 precursor [7], (b) at neutral pH
when it binds the sialic acid receptor [8,9], and (c) prior to
membrane fusion—in the acidic pH of the mature endosome
[10]. We focus on the binding of HA to the receptor and
therefore on its structure at neutral pH (Fig. 1). HA has a
long stem structure of about 135 A˚, oriented roughly
perpendicular to the virus membrane and bridging the virus
with the host cell plasma membrane. HA is a homotrimer
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comprised of an elongated coiled-coil (f 80 A˚) with a
globular domain at the top. Three long a-helices of HA2
(Fig. 1, yellow), each from a different monomer, form the
coiled-coil structure. The globular domain contains a part of
HA1 of each monomer (Fig. 1, green) and includes three
receptor-binding sites, marked in red. The fusion peptide,
marked in blue, is located about 100 A˚ away from the sialic
acid binding site.
In the process of studies aimed at identifying residues
that are crucial for membrane fusion, we mutated residues in
the HA fusion peptide. Since binding of the virus to the
target cell is a pre-requisite for fusion, we expressed the HA
mutants in COS7 cells and examined their ability to confer
binding of red blood cells (RBCs) to the HA-expressing
cells. Surprisingly, although the mutations are about 100 A˚
away from the binding site, some of them significantly
altered the ability of the HA-expressing cells to bind RBCs.
The results of the mutagenesis study are reported below
together with calculations to support an explanation of this
observation.
At least two conformations were detected for the mature
HA molecule [11]. The first was obtained at neutral pH [8]
and is usually referred to as the native structure (N). The
second was obtained at acidic pH [10], and is referred to as
the fusogenic structure (F) because of its fusogenic capacity.
The available experimental data indicate that F is stable
while N is only metastable [1,12–14] (reviewed in Ref. [3]).
That is, the free energy of the N form, GN, is higher than the
free energy of the F form, GF. The conformational change
that occurs after a pH drop switches the HA protein from the
metastable form N to the stable form F through the partially
denatured form D, whose free energy is GD (Fig. 2a). The
free energy difference GD–GN is the height of the kinetic
barrier governing the transformation. This energy barrier is a
measure of the stability of the N form; the higher it is, the
more stable the N form is. Our working hypothesis, pre-
sented in the thermodynamic cycle of Fig. 2B, is that the
binding level of HA to its cell-surface receptors is influ-
enced by the stability of the metastable form N. In other
words, for some mutants, the free energy barrier GD–GN is
reduced compared to that of the wt, rendering these mutants
less stable than the wt. This may result in HA switching
conformation from N to another conformation, such as F,
which may be more stable but with less capacity to bind to
cell-surface receptors. In this respect, it is noteworthy that in
the absence of a target membrane, exposure of virions or
cells expressing HA to low pH, presumably involving the
shift of HA from the N to the F form, was shown to
inactivate the fusion activity of HA of some influenza
subtypes, including the X:31 strain used here, and to reduce
its lateral mobility in the membrane [15–18].
To calculate the height of the free energy barrier GD–GN
of each mutant relative to the wt, we need the structures of
the wt and each mutant at the N and D forms. We assume
that the structures of the HA mutants (single or double
mutations) in the N conformation are fairly similar to the
known structure of the wt HA. However, we do not know
the structure of neither the wt nor the mutants in the D form.
Therefore, we assume that during the conformational
change from N to F, the HA protein undergoes denaturation
which is limited to the fusion peptide site. In the calcu-
lations, we approximate the structure of the denatured fusion
Fig. 1. A ribbon diagram of influenza HA in its (metastable) conformation
at neutral pH, referred to as the ‘‘N’’ form. The elongated stem structure
connects the virus at the bottom end to the membrane of the host cell at the
top end. The HA1 and HA2 subunits are colored in green and yellow,
respectively. Residues Tyr98, Trp153, His183, Glu190, Leu194, Cys97,
Pro99, Cys139, Pro147, Tyr195 and Arg229 of HA1 comprise the sialic
acid binding site and are colored red. They are located about 100 A˚ from
the 20 residues of the ‘‘fusion peptide’’ at the N-terminus of HA2 (blue).
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peptide (wt and mutants) as an extended conformation.
Further, we assume that the dominant contribution to the
stability free energy is from the nonpolar contributions to
the solvation free energy, that comprise van der Waals’ and
solvent structure effects which together define the classic
hydrophobic effect. Thus, we built the structure of each
mutant by modifying residues in the known X-ray structure
of HA wt (in the N form) and estimated the nonpolar
solvation contributions to the stability free energy of each
mutant relative to the wt by calculating the difference in the
accessibility of each HA to the solvent. Despite the crude
model, the method successfully reproduced the experimen-
tal data, supporting the assumption that reduced stability of
the metastable N conformation shifts the HA population
towards a conformation with higher stability but reduced
receptor-binding capability.
2. Theory
The thermodynamic cycle of Fig. 2b introduces a simple
interpretation of the experimental data. It assumes that HA
binds to sialic acid-containing receptors only in its native
conformation at neutral pH (N), which is metastable as
mentioned above. HA mutants and wt in their N conforma-
tion have approximately identical affinities to sialic acid
residues, and the difference in binding results from stability
differences between mutants and wild-type. This occurs
because destabilization of the N form shifts HA molecules
to more stable but binding-incompetent conformations such
as F. In the following, we present a simple approach for
estimating the stability differences.
Protein stability is related to the unfolding free energy,
defined as the free energy difference between the protein in
Fig. 2. (a) The relative free energy of HA along a hypothetical path from the native form (at neutral pH) ‘‘N’’, through the partially denatured form ‘‘D’’,
to the fusogenic form (at acidic pH) ‘‘F’’. The scheme illustrates the metastable nature of the N form. (b) Thermodynamic cycle relating the stability of
wild-type (wt) and mutant HA trimers in the metastable native-state N (solid shapes) to their partially denatured state D (scribbled line). The HA mutants
are represented by the additional black spots. DGunfold(wt) and DGunfold(m) are the unfolding free energies of wild-type and mutant HA. Our assumption is
that the capacity of HA to bind to cell-surface receptors is effected by the stability of the molecule in the metastable form N, i.e., by the free energy of HA
in its D and N forms, which corresponds to the barrier height in (a). Thus, the measured binding differences between mutant and wild-type HA, DDGbind,
are related to their stability differences, DDGstab. That is, DDGbindcDDGstabuDGunfold(wt)DGunfold(m). It is evident from the thermodynamic cycle
that DDGstab =DG
N(wt!m)DGD(wt!m), where DGN(wt!m) is the free energy difference between mutant and wild-type HA in their N forms and
DGD(wt!m) is the free energy difference between mutant and wild-type HA in their D forms.
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its unfolded and folded forms. The unfolding free energy
includes many covalent and noncovalent terms, and it is a
very difficult—usually impossible—task to calculate it from
first principles. However, the relative stability of a protein
mutant
DDGstabuDGunfoldðwtÞ  DGunfoldðmÞ
¼ DGNðwt ! mÞ  DGDðwt ! mÞ ð1Þ
is easier to estimate because of the high similarity between
the wild-type and mutant proteins. For example, the covalent
bonds of the wild-type and the mutants are usually virtually
identical and therefore it is not necessary to consider them.
Thus, one is typically left only with noncovalent contribu-
tions, such as hydrogen bonding, salt bridge formation,
solvation free energy and contributions from residue con-
finement effects. The general view is that the main contri-
bution to the relative stability of proteins comes from the
solvation free energy [19–26]. We take this view to the
extreme, assuming that the unfolding free energy difference
between a mutant and wild-type protein in their native forms
(DGN(wt!m)) and in their unfolded forms (DGD(wt!m))
can be approximated by the nonpolar contributions to the
solvation free energy alone, neglecting all the other free
energy components. Thus, denoting the nonpolar contribu-
tions to the solvation free energy of the mutant and wild-type
protein by GN np(m) and GN np(wt), we get
DGNðwt ! mÞuGNðmÞ  GNðwtÞcGNnpðmÞ
 GNnpðwtÞ ð2Þ
and an analogue expression for DGD(wt!m).
The nonpolar contribution to the solvation free energy
has entropic origin and is assumed to be proportional to the
water accessible surface area of the molecule [27]. Thus,
DGN(wt!m) is given by the expression
DGNðwt ! mÞccðSNðmÞ  SNðwtÞÞ ð3Þ
where SN(m) and SN(wt) are the water accessible surface
areas of the mutant and wild-type in their native state, and c
is a surface area proportionality constant (commonly
referred to as a surface tension). Eq. (3) and its equivalent
for the mutant and wild-type proteins in their unfolded
forms are the key equations in this study and we used them
to estimate the relative stability of each mutant with respect
to HA wt. Typical c values are in the range 0.02–0.05 kcal/
(molA˚2) [20]. As we discuss further below, the exact value
of c does not matter for the purpose of this work, and we
used c = 0.0278 kcal/(molA˚2), a value that has been derived
from the partitioning of alkanes between liquid alkane and
water [28].
Obviously HA mutants that involve the replacement of
large residues with small ones yield a decrease in the
accessible surface area of the denatured form, i.e.,
SD(m) < SD(wt). Thus, they lead to negative DGD(wt!m)
values. In contrast, the value of DGN(wt!m) of such
mutants is context-dependent. If the residue is solvent-
exposed, the replacement leads to negative DGN(wt!m)
values. In such a case, DDGstab of Eq. (1) will be small, i.e.,
the HA mutant and wt will be approximately equally stable
in the N state and their cell-surface binding capacity will be
similar. However, HA mutants involving the replacement of
large buried residues with small ones, yield an increase in
the accessible surface area, i.e., SN(m)>SN(wt), because a
water cavity is formed in our model of the protein structure.
In such a case, DDGstab will be large, leading to reduced
cell-surface binding of the HA mutant compared to wt. In
reality, the structure of the mutant HA is likely to relax and
close the cavity. Thus, our estimate of the magnitude of
DGN(wt!m) is an upper bound for the real value. Like-
wise, our approximation of the denatured form as extended
conformation maximizes the magnitude of its contribution.
Thus, DGD(wt!m) is also an upper bound to the real
value.
Eq. (3) implies that protein stability is linearly propor-
tional to the water accessible surface area and that large
globular proteins are therefore more stable than small
ones. This is not necessarily true; Eq. (3) may be useful
for estimating the relative stability of mutants, but is
unlikely to hold for the comparison of two different
proteins.
3. Materials and methods
3.1. Computational methods
The main problem in estimating mutation effects on
protein stability is that changes corresponding to several
kcal/mol or less are the result of large opposing contribu-
tions that nearly balance each other. To avoid this problem
we relied, in essence, on the known X-ray crystal structure
of HA and used Eqs. (1) and (3) to calculate the main
contributions to protein stability, i.e., the solvation free
energy. We also limited our analysis to the vicinity of the
fusion peptide.
3.1.1. Structure of the wild-type
The X-ray crystal structure of the HA trimer–sialic acid
complex was taken from entry number 1HGF in the PDB
(http://www.rcsb.org/pdb/). Several sugar and water mole-
cules have been observed in the crystal structure. They are
scattered on the surface of the protein and we omitted them
from the calculations since none of them were in direct
contact with the binding site or the fusion peptide. Hydro-
gen atoms were added to the crystal structure using the
molecular modelling set of tools in Insight97/Biopolymer
(MSI, San Diego, CA, USA). The structure was then
energy-minimized, using 200 steepest descent iterations
and the cuff forcefield with a dielectric constant of 20 in
order to adjust the molecule to the forcefield. The minimi-
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zation had very little effect on the structure and the heavy-
atoms RMS deviation between the minimized and non-
minimized structures is only 0.2 A˚.
3.1.2. Structures of mutants
Three-dimensional models of the mutants were built by
altering residues in the minimized structure of the wild-type
HA using Insight97/Biopolymer. The amino acids in a
sphere of radius 15 A˚ around the geometric center of each
mutated residue were then energy-minimized. Again, the
minimization had a very limited effect and the heavy-atoms
RMS deviations between the wild-type and each of the
mutants never exceed 0.07 A˚.
3.1.3. The denatured form
The denatured form was approximated as an extended
state and we used Insight97/Biopolymer to build tripeptides
corresponding to mutated residues and their nearest neigh-
bors. Two models were built for each case; one with the
wild-type residue and one with the mutant.
3.1.4. Nonpolar solvation free-energy calculations
The computation of the nonpolar contribution to the free
energy is based on the difference between the water acces-
sible surface area of the wild-type and mutant proteins (Eq.
(3)). The total area of the wild-type and each of the mutants
accessible to water was calculated using SurfV [29] (a
computer program based on a modified Shrake and Rupley
algorithm [30]), a water probe radius of 1.4 A˚, and the
atomic radii of the PARSE set of solvation parameters [28].
Only residues located within a radius of 7 A˚ from the
geometrical center of each mutated residue were included in
these calculations to reduce the error.
3.2. Experimental methods
3.2.1. HA mutants
HA mutants were generated by site-directed mutagenesis
[31] on single-stranded phagemids of pSM-HA [32] (an
SV40 phagemid containing the full-length X:31 HA
cDNA). The vector was used as a single-stranded bacter-
iophage for mutagenesis and as a vector for transient
expression under SV40 promoter. All mutants were verified
by sequence analysis.
3.2.2. Transfections
COS7 cells in 60 mm dishes were transiently transfected
with 3 Ag DNA of each HA mutant in pSM, using Trans-
fectamk (Promega). After 24 h, the cells in each dish were
replated into two 60 mm dishes. One dish served for
measuring RBC binding, and the other for determination
of HA surface expression level by biotinylation (see below).
This protocol ensures that the surface HA level is measured
for the same transfected dish used for the binding assay.
Forty-eight hours later, the cells were treated with neurami-
nidase (0.2 mg/ml) and TPCK-trypsin (10 Ag/ml; Sigma) as
described in Ref. [33] to cleave cell-surface HA0 to S–S
linked HA1/HA2, and taken for surface biotinylation and
RBC binding experiments.
3.2.3. Determination of cell-surface levels of HA mutants by
surface biotinylation
The 60 mm dishes with the HA-expressing COS7 cells
described above were chilled and treated with the mem-
brane-impermeable biotinylating reagent sulfosuccini-
midyl-6-(biotinamido) hexanoate (NHS-LC-Biotin;
Pierce) as described in Ref. [34]. The cells were lysed
Fig. 3. Representative fluorescence micrographs of R18-RBCs bound to COS7 cells expressing different HA mutants. R18-RBCs were bound to COS7 cells
expressing various HA mutants as described in Experimental methods. (a) I6Q (+++), (b) I10N_N12I ( + + ), (c) W14Q (+/ ), (d) W14S ( + ).
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in 0.5 ml lysis buffer (50 mM Hepes pH 7.5, 1% NP-40,
containing 1 mM PMSF, 2 Ag/ml leupeptin, 4 Ag/ml
aprotinin, and 0.5 mM iodoacetamide), spun in a micro-
fuge to remove insoluble material, and immunoprecipi-
tated with 2 Ag/ml of HC3 mouse monoclonal IgG [35] (a
gift from Dr. J.J. Skehel) as described in Ref. [34]. After
precipitation using protein A-agarose, the immunocom-
plexes were washed three times with wash buffer (20 mM
Hepes, 130 mM NaCl and 1% NP40). The pellets were
suspended in 40 Al of Laemmli loading buffer (containing
SDS and mercaptoethanol), boiled 5 min, and subjected to
SDS-PAGE on 10% acrylamide gels. The proteins were
electroblotted onto nitrocellulose membranes, and the bio-
tinylated proteins were identified by labeling with strepta-
vidin-HRP (Pierce) (1 Ag/ml, 1 h, 4 jC) and ECL
(Amersham) as described in Ref. [36]. Densitometry was
performed on a BioImaging System 202D (Dynco-Renium)
using TINA 2.0 software (Ray Test).
3.2.4. Binding of R18-RBCs to HA-expressing cells
Freshly drawn RBCs were labeled with the fluorescent
lipid probe octadecylrhodamine B chloride (R18; Molecular
Probes) as described in Ref. [33]. The R18-RBCs were
suspended in RPMI medium (Biological Industries, Beth
Haemek) supplemented with 50 mM Hepes (pH 7.4), stored
at 4 jC and used within 4 days. For binding to HA-
expressing COS7 cells, each 60 mm dish was incubated
with 2 ml of 0.05% hematocrit of R18-RBCs in the RPMI/
Hepes medium (20 min, 25 jC) and washed three times.
The binding levels were evaluated by counting the number
of R18-RBCs bound to 200 cells in each sample under a
fluorescence microscope with rhodamine filters. We
employed a binding index relative to HA wt (which was
always measured in parallel and was taken as 100%): (+++)
indicates R18-RBC binding level similar (F 10%) to that of
HAwt; (+ + ) stands for f 70% binding; (+/ ) indicates
f 40% binding; and ( + ) stands for 5% binding or less
relative to HA wt.
4. Results
4.1. Experimental results on RBC binding to HA-expressing
COS7 cells
A series of mutants (13 single and 3 double mutations) in
the fusion peptide region of X:31 HA were prepared as
described in Experimental methods (Table 1). Each mutant
was transiently expressed in COS7 cells, and their ability to
bind fluorescent-labeled RBCs (Fig. 3, Table 1) was meas-
ured. When comparing the levels of RBC binding to cells
expressing different HA mutants, it was important to elim-
inate the possible contribution of variations in the surface
expression levels of the different mutants. Such variations
may arise due to differences in transfection efficiency and in
transport of the different mutants to the cell surface. There-
Fig. 4. Cell-surface expression of representative HA mutants. COS7 cells
expressing HA wt and representative mutants were transfected in parallel.
The cells in each dish were split into 60 mm (for binding studies) and 30
mm (for surface HA level determination) dishes, and the latter were labeled
with membrane-impermeable NHS-LC-Biotin as described in Experimental
methods. After immunoprecipitation with anti-HA, SDS-PAGE and
blotting, biotinylated HA was visualized by labeling with streptavidin-
HRP and ECL (see Experimental methods). (A) I6Q, (B) I10N_N12I, (C)
W14Q, (D) W14S, (E) HA wt. All the HAs exhibited similar expression
levels on the cell surface; RBC binding studies employed transfected
samples where the variations in HA surface expression levels did not
exceed 10%.
Table 1
The experimentally measured RBCs-binding and calculated stability of the
HA mutants in the metastable N state (Fig. 2a) compared to wt
Mutanta Calculated stability Measured
DGD(wt! m)
c
(kcal/mol)
DGN(wt!m)
d
(kcal/mol)
DDGstab
e
(kcal/mol)
Estimated
bindingf
bindingb
I6Y 3.7  0.4  4.1 (+++) (+++)
F3Y_F9Y 2.2  0.9  3.1 (+++) (+++)
F9Y 1.1  0.3  1.4 (+++) (+++)
I6Q  0.1  0.4  0.3 (+++) (+++)
I18Q_F24Y 1.1 1.1 0.0 (+++) (+++)
L2Q  0.7  0.5 0.2 (+++) (+++)
I10Q  0.1 0.8 0.8 (+++) (+++)
I18Q  0.1 1.4 1.5 ( + + ) (+++)
W14Y  2.3  0.1 2.2 ( + + ) (+++)
W14F  3.5  0.3 3.2 ( + + ) (+++)
I10N  2.6 1.0 3.6 ( + + ) (+++)
I10N_N12I  0.5 0.4 1.0 ( + + ) ( + + )
W14M  5.1 1.0 6.2 (+/ ) (+/ )
W14Q  6.6 1.5 8.2 (+/ ) (+/ )
W14S  11.5 3.3 14.8 ( + ) ( + )
W14A  12.4 4.0 16.4 ( + ) ( + )
a The list of mutations in single-letter amino acid symbols. The
numbers relate to the location in the fusion peptide, starting with 1 at
position 347. For example, I6Y is a mutant where Ile6 was replaced by Tyr,
and F3Y_F9Y is a double mutant (at positions 3 and 9).
b The measured RBCs-binding index divided into four groups: (+++)
indicates binding similar to the wild-type, ( + + ) indicates binding at
about 70% of wild-type, (+/ ) indicates binding at about 40% of wild-type
and ( + ) binding at about 5%.
c Relative stability of mutant and wild-type HA in the denatured forms.
The value reported is for a trimer, i.e., three times the calculated value per
monomer.
d Relative stability of mutant and wild-type HA in the (metastable)
folded trimeric forms.
e The stability free energy difference between wild-type and mutant
HA, Eq. (1).
f An arbitrary conversion of the calculated relative stability into binding
index (see text for details).
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fore, for each set of comparative experiments performed on
the same day, we used the same transfection buffer mix, the
same suspension of fluorescent-labeled RBCs for the bind-
ing assay, and always included a sample transfected with
HA wt as an ‘‘internal reference’’ (taken as 100% binding).
Most importantly, the amounts of each mutant at the cell
surface (which reflects a combination of both transfection
efficiency and arrival at the cell surface) were measured on
samples taken from each transfected dish by labeling cell-
surface proteins with a membrane-impermeable biotinyla-
tion reagent, followed by immunoprecipitation of HA and
Western blotting (see Experimental methods). Fig. 4 depicts
a representative example of one set of such experiments. In
general, the surface expression levels of all the mutants
studied here were very close; the RBC binding studies
employed transfected samples where the variations in HA
surface expression levels did not exceed 10%.
The results of the RBC binding studies are summarized in
Table 1. The various HA mutants fell into four major groups.
Cells expressing the mutants I6Y, F3Y_F9Y, F9Y, I6Q,
I18Q_F24Y, L2Q, I10Q, I18Q, W14Y, W14F and I10N
bound the same amount of RBCs as HA wt (designated
+++). The RBC binding capability of the I10N_N12I mutant
was somewhat less than that of HA wt (f 70%, designated
+ + ). The amount of RBCs bound by the W14M and
W14Q mutants was f 40% of that bound by HAwt (+/ ).
Finally, two mutants (W14S and W14A) showed very low
RBC binding (less than 5% relative to HA wt; marked as
+ ). It is evident from the data that most of the mutations
that involve replacement of residues of similar size had little
effect on the ability to bind RBCs and that the reduction of
the binding is proportional to the size difference between the
amino acids of HA wt and the mutant. Our theoretical
explanation is based on this observation.
4.2. Calculations
We used Eqs. (1) and (3) to calculate DDGstab as
described in Computational methods. The results are pre-
sented in Table 1. The table depicts a good inverse
correlation between the measured RBC binding and the
calculated stability free energy of HA in its metastable state
N; strong binding is correlated with small DDGstab, while
weak binding is correlated with large DDGstab. To visualize
the results and to facilitate quantitative comparison of the
experimental data to the calculations, we processed the
experimental data to fit a presentation as a diagram. The
calculated values span a free energy range of 16.4–
( 4.1) = 20.5 kcal/mol, while the experimental data is
reported in terms of four levels of binding: (+++),
(+ + ), (+/ ) and ( + ) that presumably correlate with
the same free energy range. Thus, we scaled the calculated
data to the experiments by fitting the extreme values of the
calculations and measurements, i.e.,  4.1 kcal/mol to
(+++) and 16.4 kcal/mol to ( + ). The correlation
implies that the ‘‘measured’’ free energy difference between
each of the four levels is 20.5/4 = 5.1 kcal/mol, and thus the
four levels are as follows: (+++) corresponds to the free
energy range  4.1–1 kcal/mol, (+ + ) corresponds to the
range 1–6.1 kcal/mol, (+/ ) corresponds to 6.1–11.3 kcal/
mol and ( + ) to 11.3–16.4 kcal/mol. The results of the
scaling procedure are listed in Table 1 and are plotted in
Fig. 5.
The chart in Fig. 5 shows the measured binding of the
HA mutants relative to the wild-type compared to the
calculated relative stability free energy of HA in its meta-
stable form N. The mutations are plotted in decreasing order
of the experimental binding index from (+++) to ( + )
and the figure shows the overall agreement between the
Fig. 5. The calculated stability (Fig. 2) and the measured R18-RBC binding of the HA mutants. The black and gray columns represent the experimental results
and the calculations, respectively. The values are taken from Table 1. See text for details.
D. Shental-Bechor et al. / Biochimica et Biophysica Acta 1565 (2002) 81–90 87
measurements and calculations over the entire range. Very
good agreement is observed for 12 out of the 16 mutants
that we have tested and the discrepancy between the
experimental data and the calculations for the four other
mutations does not exceed one level.
One-level deviations between measurements and calcu-
lations are observed for four single mutants: I18Q, W14Y,
W14F and I10N. In all of these cases, the calculated value
exceeds the measured value, presumably because of the
oversimplified computational scheme that we used. This
issue is discussed below.
5. Discussion
We carried out a mutagenesis study to explore whether
the structure of the fusion peptide can alter HA binding to its
cell-surface receptors at the distal site. Our main experi-
mental observation is that some of the mutations reduced the
binding ability, even though the fusion peptide and the
receptor-binding site are about 100 A˚ away from each other
and on two different HA subunits. The key observation here
is that replacing residues with same-size residues had little
or no effect on HA’s cell-surface binding, while the replace-
ment of large buried residues with small ones reduced the
binding. The latter type of residue replacements is likely to
lead to the creation of cavities in HA and to its destabiliza-
tion. Since it is commonly found that reduced protein
stability leads to reduced function [37], the simplest possible
explanation for our experimental observation is that muta-
tions that are associated with reduced stability of HA lead to
reduced binding to cell-surface receptors.
Work by Sauter et al. [38,39] on pure molecules in
solution indicated that native HA, low pH HA, and the
isolated globular receptor-binding domain of HA all bind
sialic acid with similar affinities. Thus, it might have been
anticipated that it would be difficult to find mutations
outside the receptor-binding domain itself that would com-
promise HA’s function. However, the available experimental
data suggest that the situation is much more complex for
intact membrane-attached HA. For example, the exposure of
virions or cells expressing HA to low pH, which presumably
involves the shift of HA from the N to the F form, prior to
providing them with a target membrane, was shown to
inactivate the fusion activity of HA of the X:31 strain and
to reduce its lateral mobility in the membrane [15–18].
The reason for the apparent conflict between studies of
HA fragments in aqueous solutions vs. studies of the intact
molecule in virions or cellular systems is unclear. One
possible explanation is that pre-exposed fusion peptides in
the latter experiments may stick to each other or to hydro-
phobic regions on HA or on the cell (or virion) membrane
and may restrain HA’s accessibility to its cell-surface recep-
tors. In view of these findings (and regardless of the
resolution of the conflict), we suggest here that the reduction
in the stability of HA in the N conformation (Fig. 2a) may
indeed impair the capacity of membrane-attached HA to bind
to cell-surface receptors. The fact that, unlike most other
proteins, the native (N) conformation of HA is metastable
gives further support to our assumption, and the calculations
of Table 1 and Fig. 5 consolidate it. In the following para-
graphs, we discuss some limitations of the experimental
methodology, the computational scheme, and the procedure
used for relating the experimental and computational data.
Conducting experiments for accurately measuring the
free energy of binding of HA to its sialic acid-containing
receptors is difficult because these receptors comprise a
heterogeneous population of many proteins and lipids;
furthermore, these receptors are located at the cell surface
and their availability and exact conformation may also
depend on the membrane lipid environment. However, for
the purpose of this study it was sufficient to get an estimate
of the relative binding capacity of HA mutants compared to
HA wt, which we did by measuring the binding of fluo-
rescent-labeled RBCs to HA-expressing cells (see Exper-
imental methods). The approximated experimental data thus
obtained calls for a simple computational scheme of the type
we used to interpret the data.
The method of choice for calculating the stability differ-
ence between HA mutants and HA wt (in their ‘‘N’’
conformation) is free energy perturbation using molecular
dynamics simulations. The technique is well established and
is the main computational tool for estimating the effects of
mutations on binding and stability in biomolecules. It has
been used to reproduce binding free energy differences
between mutant and wild-type protein forms and yielded
results in excellent agreement with experimental data [40].
Free energy calculations can, in principle, include all the
free energy terms, contributions from internal energy and
conformational entropy effects, as well as solvation free
energy—provided that the simulations are carried out in
water environment. Thus, they should be superior to our
calculations that take into account only the nonpolar con-
tribution to the solvation free energy (Eq. (3)).
However, molecular dynamics simulations for large
systems, such as the HA trimer in water, are cpu time-
demanding and the alternative simplified model that we
chose provides a reasonable alternative—especially that the
exact value of the free energy matters less than the relative
value. It should be noted that the measured binding is only
semi-quantitative; it is reported in levels relative to HA wt
rather than as a free energy value.
External effects, such as the salt concentration, the pH
and the temperature, are not included in our theoretical
model and thus the approach is suitable only for the
comparison of mutants at similar environment, e.g., phys-
iological conditions as we used here.
One of the main difficulties of our study was to relate the
estimate of the stability free energy in kcal/mol to the
experimental data, reported in percent binding relative to
HAwt. Since the trend matters more than the actual value in
this study, we suggested the simplest possible relation, i.e.,
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that the experimental data and the calculations are linearly
proportional to each other, and our results are in agreement
with this assumption. Another difficulty is that the actual
value of the calculated stability free energy depends on the
choice of the surface tension coefficient, c, in Eq. (3).
Typical c values are between 0.02 and 0.05 kcal/(mol A˚2)
[41] and we arbitrarily used a value of 0.0278 kcal/(mol A˚2)
that has been derived from experimental data of transferring
alkane molecules from cyclohexane to water [28]. However,
it is noteworthy that the actual value of c is not important for
this study; our results show that the difference in the water
accessible surface area between HA mutants and wt is
linearly proportional to the measured difference in binding.
The choice of c determines only the range of the calculated
values—about 20 kcal/mol in our case; had we chosen a
smaller value of c, the range to be obtained would be
smaller but the proportion would not be altered.
Despite its limitations, our computational scheme pro-
vides estimates of changes in the binding-capability that
agree well with the trend of the experimental data. This is
presumably because we focused on the main contribution to
protein stability and thus avoided the problem of subtracting
very large values to estimate small changes in protein
stability. The success of our scheme further supports the
general view that the main contribution to the stability free
energy is the nonpolar solvation term and that the other
contributions probably cancel each other out approximately.
The approximated computational scheme was only used
as a tool for interpreting the experimental data and our
experimental and computational data suggests that distant
mutations affect binding of HA to its receptors by changing
the stability of the HA molecule in its metastable N con-
formation. This suggestion is further supported by proline
scanning studies of HA. In these studies, we demonstrated
that binding of the four HA mutants: A7P, N12P, M17P and
Y22P to the cell-surface receptor is completely abolished.
The mutation of each of these residues to proline presum-
ably destabilizes HA in its metastable N conformation to a
degree where almost all the mutant HA molecules shift to
binding-incompetent conformations such as F, essentially
eliminating the binding to cell-surface receptors. Proline
mutations are likely to yield significant structural changes,
i.e., the mutants’ structures are likely to deviate significantly
from HA wt, so that our computational scheme probably
cannot be used as discussed above. Thus, we did not attempt
to calculate the change in the stability free energy of the
proline mutants.
The success of our model in the interpretation of the
seemingly puzzling experimental data would be substanti-
ated by demonstrating that the mutations affect HA stability.
However, such studies are not feasible within the scope of
the current work because they would require purification of
all the HA mutants either as GST-fusion proteins in bacteria
or in insect cells. Moreover, in view of the conflict between
the results obtained by Sauter et al. [38,39] for purified/
solubilized HAs and the data presented here for membrane-
anchored intact HAs, even if such studies (on solubilized
HAs) were performed, their merit might be questionable. In
this context, it should be noted that HA is not homoge-
neously distributed in the membrane, but rather is associated
with cholesterol- and sphingolipid-enriched raft domains
[42,43]. This further complicates the comparison between
studies on solubilized and membrane-attached HAs.
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